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Background: Lannea schweinfurthii, Zanthoxylum capense, Scadoxus puniceus and Crinum bulbispermum are used
traditionally to treat neurological disorders. The aim of this study was to evaluate the cytoprotective potential of the
four plants, after induction of toxicity using rotenone, in SH-SY5Y neuroblastoma cells.
Methods: Cytotoxicity of the plant extracts and rotenone was assessed using the sulforhodamine B (SRB) assay.
Fluorometry was used to measure intracellular redox state (reactive oxygen species (ROS) and intracellular glutathione
content), mitochondrial membrane potential (MMP) and caspase-3 activity, as a marker of apoptotic cell death.
Results: Of the tested plants, the methanol extract of Z. capense was the least cytotoxic; LC50 121.3 ± 6.97 μg/ml, while
S. puniceus methanol extract was the most cytotoxic; LC50 20.75 ± 1.47 μg/ml. Rotenone reduced intracellular ROS levels
after 24 h exposure. Pre-treating cells with S. puniceus and C. bulbispermum extracts reversed the effects of rotenone on
intracellular ROS levels. Rotenone exposure also decreased intracellular glutathione levels, which was counteracted by
pre-treatment with any one of the extracts. MMP was reduced by rotenone, which was neutralized by pre-treatment
with C. bulbispermum ethyl acetate extract. All extracts inhibited rotenone-induced activation of caspase-3.
Conclusion: The studied plants demonstrated anti-apoptotic activity and restored intracellular glutathione content
following rotenone treatment, suggesting that they may possess neuroprotective properties.
Keywords: Caspase-3, Crinum bulbispermum, Glutathione, Lannea schweinfurthii, Mitochondrial membrane potential,
Neuroprotection, Reactive oxygen species (ROS), Rotenone, Scadoxus puniceus, Zanthoxylum capenseBackground
Parkinson’s disease (PD) is the second most common
progressive age-related neurological disorder. It is esti-
mated to affect more than 6 million people worldwide
[1]. The prevalence of the disease is reported to be 1-2%
amongst those who are over 65 years and about 4%
amongst individuals who are older than 80 years [2,3].
The disease is characterized by a marked selective
degeneration and loss of dopaminergic neurons in the
brainstem region, specifically the substantia nigra pars
compacta, causing impaired dopamine signaling [4].
In order to investigate PD, use is made of an in vitro
neuronal cell model. In the present study SH-SY5Y
neuroblastoma cells were used since these cells share* Correspondence: vanessa.steenkamp@up.ac.za
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article, unless otherwise stated.various biochemical and functional characteristics of
innate neurons [5]. These include: the expression of
dopamine and noradrenaline producing enzymes, acetyl-
choline, norepinephrine and various growth factor recep-
tors [6]. Neurotoxins, such as environmental pesticides
and herbicides that produce PD-like symptoms in vivo, are
commonly used to study PD in different neuronal cell
lines [7,8]. It is thought that the pesticide, rotenone,
induces PD-like symptoms in neurons through disrupting
adenosine triphosphate (ATP) supply [9]. This happens
when rotenone forms a complex with members of the
mitochondrial electron transport chain (ETC), specifically
at complex I, resulting in limited ATP production [10].
Presently, there is no cure for PD [11]. Existing thera-
pies are aimed at increasing CNS dopamine levels,
enhancing dopaminergic cell survival and modifying
clinical PD symptoms [12,13]. Unfortunately, most ofCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
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resulted in extensive research into complementary and
alternative medicines that may be of benefit [16,17]. In
the United States, United Kingdom and Korea, approxi-
mately 40%, 39% and 76% of PD patients, respectively,
have admitted to self-medicating in the form of herbal
remedies [16,18].
Four herbal remedies which are either traditionally
reported to be used in the treatment of neurological dis-
orders or which are implicated in neurological disorders
were selected for investigation. Infusions of the roots of
Lannea schweinfurthii (Anacardiaceae) are reported to
enhance memory and are used as a sedative [19,20]
whereas decoctions of the roots of Zanthoxylum capense
(Rutaceae) are used to treat epilepsy [21]. The bulbs of
Crinum bulbispermum and Scadoxus puniceus (Amaryl-
lidaceae) are reported to possess anticonvulsant activity
and cause CNS excitation and depression, respectively
[22,23]. The aim of this study was to investigate the
cytoprotective potential of these four herbal remedies
against rotenone-induced toxicity in SH-SY5Y neuro-
blastoma cells.
Methods
Plant specimens and preparation of extracts
The plants investigated in this study were either a gift
from the South African National Botanical Institute
(SANBI, Tshwane) or collected by an expert botanist in
Venda, Limpopo. Voucher specimens of the plants are
deposited at the SANBI herbarium or in the Department
of Toxicology (Onderstepoort Veterinary Institute,
Pretoria).The plants investigated included: the root-bark
of Lannea schweinfurthii (Engl.) Engl. (voucher LT 19),
roots of Zanthoxylum capense Thunb. Harv (voucher LT
4), and the bulbs of Scadoxuspuniceus (L.) Friis & Nordal
(voucher SANBI) and Crinum bulbispermum (Burm. f.)
Milne-Redh.&Schweick (voucher SANBI).
Plant material was air-dried and ground to a fine pow-
der using a Wiley Mill (Model no 2, Philadelphia U.S.A).
Ground plant material (1.5 g) was extracted with 15 ml
of either methanol or ethyl acetate. Extracts were in-
cubated at room temperature in an ultrasonic bath
for 30 min and then placed on an orbital shaker for a
further 2 h, after which they were incubated at 4°C for
approximately 20 h. To separate debris, extracts were
centrifuged at 1000 × g for 10 min, syringe-filtered
(0.22 μM) and dried under reduced pressure using
a rotary vacuum evaporator (BUCHI Rotavapor R-200,
LABOTEC). Dried extracts were reconstituted in di-
methylsulfoxide (DMSO) and aliquots stored at −20°C
until use. Yields were: L. schweinfurthii 4.0% and 4.3%; Z.
capense 18.3% and 4.2%; S. puniceus 8.7% and 4.5% and C.
bulbispermum 3.7% and 14.0% for the methanol and ethyl
acetate extracts, respectively.Cell culture maintenance and harvesting
SH-SY5Y neuroblastoma cells (ATCC no. CRL-2266)
were purchased from the American Type Culture
Collection and cultured in 75 cm3 culture flasks at 37°C
under an atmosphere of 5% CO2 and humidified air.
Cells were grown in Ham’s F12 medium, supplemented
with 10% heat-inactivated fetal calf serum (FCS) and 1%
penicillin-streptomycin. The medium was replaced every
2-3 days, as required. Once cells reached a confluency
of ≈ 80%, medium was discarded and cells were washed
with phosphate buffered saline (PBS). Cells were de-
tached using a 0.125% Trypsin/Versene solution and
harvested by centrifugation at 200 × g for 5 min. Cells
were resuspended in 1 ml of medium and viable cells
were counted using trypan blue (0.4% w/v in PBS).
Cytotoxicity of the individual test compounds and effects
of the plant extracts on rotenone-induced cytotoxicity
Cytotoxicity was determined using the sulforhodamine
B assay (SRB) as described by Vichai and Kirtikara [24].
Cells (100 μL, 1 × 105 cells/ml) were pre-seeded into
96-well plates followed by the addition of 80 μL of 2%
FCS-supplemented medium and incubated for 24 h. To
determine the cytotoxicity profiles of each plant extract
or rotenone alone, a volume of 20 μL of either plant
extract (final exposure concentrations of 0.78-100 μg/
ml) or rotenone (final exposure concentrations of 0.128
nM-50 μM) was added to the plates and incubated for
72 h, after which the SRB assay was performed. Vehicle
controls were exposed to 0.05% (v/v) DMSO in culture
medium and wells containing culture medium only
served as blanks. To assess the effects of the plant ex-
tracts on rotenone-induced cytotoxicity, cells were pre-
treated for one hour with four non-toxic concentrations
of each of the plant extracts prior to being exposed to
rotenone for 72 h at concentrations of 10 nM, 50 nM
and 100 nM. Minocycline (10 μM), which is known to
counteract rotenone toxicity [25], was used as treatment
positive control throughout the study. All subsequent
experiments evaluating mechanistic parameters utilized
a rotenone concentration of 50 nM.
The SRB assay was performed as follows: After the
72 h exposure period, 100 μL of the supernatant was
aspirated from the wells and replaced with 100 μL of
cold trichloroacetic acid (TCA) solution (30% w/v). Each
plate was then incubated at 4°C for 1 h to fix cells to the
plate. After incubation, the plate was gently washed with
water (four times) to remove excess TCA. The plate was
dried in a low-temperature oven, after which 100 μL of
0.057% (w/v) SRB solution was added to wells to stain
the cellular protein contents. The plate was incubated
for 30 min at 4°C and washed twice with 200 μL of a 1%
acetic acid solution (v/v) to remove excess unbound dye.
The plate was allowed to dry, after which the bound dye
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tion (pH 10.5). Absorbance was measured at 540 nm
with a reference wavelength of 630 nm, using a Biotek
ELx 800UV Universal plate reader.
Preliminary experiments indicated that rotenone in-
duced approximately 50% cell death at a concentration
of 50 nM. For this reason rotenone was used at a con-
centration of 50 nM for all subsequent mechanistic
studies.
Intracellular reactive oxygen species
Intracellular ROS production was assessed using the
method described by Shaykhalishahi et al. [26], with slight
modifications. Briefly, following 24 h exposure to the test
compounds, 20 μL of 2’,7’-dichlorodihydrofluorescein dia-
cetate (H2DCF-DA; 20 μM) in PBS solution was added to
the relevant wells and the plates incubated for 30 min at
37ºC. Plates were then washed once with 100 μL of PBS to
remove excess H2DCF-DA solution. An additional 100 μL
of PBS was added to each well and the fluorescence in-
tensity measured using a BMG Fluostar Optima fluores-
cent plate reader set at excitation and emission
wavelengths of 492 nm and 525 nm, respectively. The
values are expressed as the mean absorbance normal-
ized to a percentage of the untreated control value. An
established ROS-inducing agent, 2,2’-azobis-2-methyl-
propanimidamide dihydrochloride (AAPH) (150 μM),
was included as an additional positive control to ensure
that the assay produced expected results.
Intracellular glutathione levels
Intracellular glutathione levels were determined using the
method of Nair et al. [27]. Following 24 h exposure to the
relevant treatment, 20 μL of monochlorobimane (40 μM)
in PBS solution was added to all the wells. The plates were
incubated for 2 h at 37°C, followed by a 100 μL PBS wash-
ing step. After the addition of 100 μl of PBS, fluorescence
intensity was recorded using a BMG Fluostar Optima set
at excitation and emission wavelengths of 360 nm and
460 nm, respectively. The glutathione depleting agent,
N-ethylmaleimide (NEM) (10 μM), was used as an add-
itional positive control to ensure that the assay produced
expected results.
Mitochondrial membrane potential
Mitochondrial membrane potential (MMP) was deter-
mined according to Sternfeld et al. [28] with minor
modifications. Briefly, after treatment of cells for 24 h,
100 μL of the supernatant was discarded and 20 μL of
5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcar-
bocyanine iodide (JC-1; 10 μM) in PBS was added be-
fore plates were incubated for 30 min at 37°C and 5%
CO2 in the dark. Excess dye was washed off using
100 μL PBS and an additional 100 μL PBS was addedfor fluorescence measurements. Fluorescence intensity
was measured using a BMG Fluostar Optima fluores-
cence microplate reader set at excitation wavelengths
of 492 nm and 520 nm, and emission wavelengths of
544 nm and 590 nm for the monomeric and aggregate
forms of JC-1, respectively. The ratio of the fluo-
rescence intensities at 590 nm (J-aggregates) / 520 nm
(J-monomers) was used as an indication of MMP. The
mitochondrial uncoupler, valinomycin (20 μM), was
used as an additional positive control to ensure that
the assay produced expected results.
Apoptosis
The assay was conducted according to the method of
van Tonder [29]. Briefly, following exposure, cells were
lysed with 25 μL of a cold lysis buffer [10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
2 mM ethylenediaminetetraacetic acid (EDTA), 5 mM3-
[ (3-cholamidopropyl )dimethylammonio]-1propanesul-
fonate (CHAPS), 5 mM beta-mercaptoethanol, 0.5 mM
phenylmethylsulfonyl fluoride (PMSF)] and kept on ice
for 30 min. Thereafter, 100 μL of reaction buffer (20 mM
HEPES, 2 mM EDTA, 5 mM β-mercaptoethanol, 0.5 mM
PMSF, 10 μM of a 7-amino-4-methylcoumarin-coupled
caspase-3 substrate) was added to wells followed by an
overnight incubation at 37ºC. Fluorescence intensity was
measured using a BMG Fluostar Optima set at excitation
and emission wavelengths of 360 nm and 460 nm, respect-
ively. Staurosporine (11 μM), a general apoptosis inducer,
was used as positive control to ensure that the assay pro-
duced expected results.
Statistical analyses
For cell viability, the concentration that produces 50%
cell death (LC50) was calculated by fitting a four-
parameter Hill equation to the observed results. Two
constraints (top = 100; bottom = 0) and a variable slope
were used for fitting the non-linear model. Calculated
LC50 values are expressed as the mean ± the standard
error of the mean (SEM).
All experiments were carried out in triplicate on
three separate occasions. Background signals (blanks)
were deducted in all experiments. Depending on the
normality of the data, either Mann–Whitney or Stu-
dent’s t-tests were performed to test for significant
differences between the means of the various groups.
Results for endpoints assays were normalized to a per-
centage of the mean of vehicle controls and are pre-
sented as mean ± SEM. Significant differences from
vehicle controls are indicated by ■ for p value < 0.05.
Significant differences between treatment groups and
rotenone treatment alone are indicated by * for p value
< 0.05. GraphPad Prism 5.0 was used for all statistical
manipulations.
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The aim of the study was to determine the effects of
methanol and ethyl acetate extracts of four South African
medicinal plants on rotenone-induced neuronal toxicity
using the SH-SY5Y neuroblastoma cell line. In vitro assays
were employed to assess cytotoxicity, intracellular redox
state (ROS and intracellular glutathione content), MMP
and caspase-3 activity, of the plant extracts. These parame-
ters were selected as oxidative stress and mitochondrial
dysfunction appear to play key roles in PD manifestation
[1]. Oxidative stress is the result of excessive free radical
levels that originate from dopamine metabolism and elec-
tron transfer in the electron transport chain during energy
metabolism [30]. Excessive free radicals deplete innate anti-
oxidant defences [31]. When this happens, mitochondrial
processes are affected causing mitochondrial dysfunction
and thus disruption in brain function [32]. Caspase-3 acti-
vation executes apoptosis [33]. The effectors of apoptosis
are responsible for the breakdown of the cellular cytoskel-
eton, mitochondrial DNA and DNA-associated proteins
leading to neuronal cell death via mitochondrial-mediated
apoptotic pathways [34].
Cytotoxicity
SH-SY5Y viability following exposure to rotenone
From an initial dose-finding pilot study rotenone was
observed to be the most cytotoxic of all the test com-
pounds with a calculated LC50 value of 112 ± 1.05 nM. A
second pilot study was conducted to test whether this
calculated concentration actually produced the predicted
50% cell death. It was found that 50 nM of rotenone re-
duced viability to 48%, when compared to the vehicle
controls. Results are in line with literature as rotenone, a
classic complex I inhibitor, is known to be toxic to sev-
eral cell lines [35]. Exposure to 0.1, 1 and 10 μM of rote-
none for 4 h has been reported to decrease the viability
of Neuro-2a mouse neuroblastoma cells by 86.78% ±
7.14%, 64.49% ± 3.41% and 50.11% ± 3.20%, respectively
[36]. Another study, which was carried out using SK-N-
MC human neuroblastoma cells, reported toxicity when
cells were exposed to concentrations ranging from 10
nM to 1 μM of rotenone for 24–48 h [9]. Results from
the present study and those reported in literature clearly
demonstrate that the toxicity of rotenone is dependent
on the concentration of rotenone and the duration of
exposure.
SH-SY5Y viability following exposure to the individual plant
extracts
The methanol extract of L. schweinfurthii produced a cal-
culated LC50 value of 78.87 ± 2.10 μg/ml, while its ethyl
acetate counterpart produced a calculated LC50 value of
36.02 ± 0.79 μg/ml. A study using a 20% aqueous-ethanol
extracts of Lannea stuhlmanii reported no significanttoxicity in human cervical carcinoma, human colon
adenocarcinoma or human skin carcinoma cells, with >
85% viability after 72 h exposure to concentrations as high
as 100 μg/ml [37]. Differences in cell type and/or plant
species may account for this discrepancy.
Exposure to Z. capense extracts produced calculated
LC50 values of 121.3 ± 6.97 μg/ml and 90.18 ± 0.56 μg/ml
for the methanol and ethyl acetate extracts, respectively.
Although the genus Zanthoxylum has been reported to
possess cytotoxic properties, the isolated compounds
alone have been reported to have negligible or no cyto-
toxic effects [38].
S. puniceus methanol extract had the lowest LC50
value (20.75 ± 1.47 μg/ml) of the plant extracts tested,
indicative of a high toxic potential. The ethyl acetate ex-
tracts of this plant had an LC50 value of 37.40 ± 0.82 μg/
ml. The ethyl acetate extract of C. bulbispermum was
the least cytotoxic with an LC50 value of > 100 μg/ml.
Contrary to this, the methanol extract produced an LC50
value of 46.18 ± 0.91 μg/ml. Both species are well-known
for their high alkaloidal content [39], and the cytotoxic
effects observed may be attributed to the presence of these
compounds.
Inhibition of rotenone-induced SH-SY5Y cytotoxicity
To determine the effects of the various plant extracts on
rotenone-induced cytotoxicity (10 nM) the SH-SY5Y
cells were pre-treated with selected sub-toxic concentra-
tions of the plant extracts (3.125, 6.25, 12.5 and 25 μg/
ml) for 1 h. The results are graphically presented in
Figure 1A and B for the methanol and ethyl acetate
extracts, respectively. The treatment positive control,
minocycline, was observed to counteract rotenone tox-
icity by maintaining cell viability at > 90%. Minocycline
is a lipophilic tetracycline antibiotic that is known to
possess anti-inflammatory and antioxidant activities,
besides its anti-bacterial activity [40-42].
With regards to the medicinal plants, both the methanol
and ethyl acetate extracts of Z. capense, S. puniceus and
L. schweinfurthii demonstrated cytoprotective properties
in cells exposed to concentrations of 10 nM of rotenone
(Figure 1). However, these same extracts did not show any
significant cytoprotective effects at rotenone concentra-
tions of 50 nM and 100 nM (data not shown).
Cellular redox state
Intracellular reactive oxygen species
Significant (p < 0.05) intracellular ROS production was
observed in cells exposed to the assay positive control,
AAPH, indicating that the assay produced expected
results (Figure 2). Compared to vehicle controls, there
was no intracellular ROS production in cells exposed to
50 nM of rotenone for 24 h. Instead rotenone exposure
significantly (p < 0.05) decreased intracellular levels of
Figure 1 Cytotoxicity results. Effect of 1 h of pre-treatment with either A) methanol or B) ethyl acetate plant extracts on the survival of SH-
SY5Y cells after 72 h exposure to 10 nM rotenone using the sulforhodamine B assay. Significant differences from the rotenone control are indicated
by* representing p value < 0.05, while significant differences from vehicle controls are indicated by ■, also representing p value < 0.05. PC = posi-
tive control (minocycline at 10 μM); Rot = rotenone; Untr = Vehicle controls. (The dashed-line indicates 100% viability of the vehicle controls while
the dotted-line is indicative of the level of cell death induced by the respective rotenone concentrations).
Figure 2 Effects on radical generation. Intracellular ROS levels in SH-SY5Y cells exposed to rotenone at 50 nM after 1 h pre-treatment with either A)
methanol or B) ethyl acetate plant extracts following 24 h exposure period. Significant differences from the rotenone are indicated by * representing
p value < 0.05, while significant differences from vehicle controls are indicated by ■, also representing p value < 0.05. PC = positive control
(minocycline at 10 μM); Rot = rotenone; Untr = Vehicle controls. (The dashed-line indicates ROS levels in the vehicle controls while the
dotted-line is indicative of ROS generation exposed to rotenone alone.
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any intracellular ROS generation, experiments were
repeated over a longer exposure period of 72 h. Still no
significant intracellular ROS production was observed in
cells exposed to rotenone alone, compared to vehicle
controls (results not shown). The mitochondrial ETC
complex I is the main site of ROS production from
mitochondria [43] and ROS production can be enhanced
by a defective mitochondrial ETC complex I [44]. This
concept is in line with the report of Molina-Jimenez
et al. [45] where rotenone induced ROS production in
SH-SY5Y cells after 16 h treatment with 5 μM of rote-
none, which stands in contrast to observations from the
present study. It is possible that the rotenone concentra-
tion used in the present study (50 nM) might have been
too dilute to achieve similar results, regardless of the
exposure time. Results similar to that of the present
study are reported from a study by Vrablic et al. [46]
conducted on hepatocytes, in which a reduction in ROS
production was observed after exposure to 50 nM of
rotenone. Contrary to this, Gao et al. [47] have shown
ROS production to be induced by 5 nM and 10 nM of
rotenone after only 30 min of exposure in primary
mesencephalic neuron glial cultures. It would appear as
if rotenone-induced ROS generation in vitro depends on
the type of cell line used, concentration of rotenone used
and time of exposure to rotenone [48].
Minocycline, at a concentration of 10 μM, was able to
counteract the effects of rotenone on intracellular ROS
levels after 24 h of exposure. Not only did minocycline
counter the effect of rotenone, it actually caused a signifi-
cant (p < 0.05) increase in intracellular ROS levels, when
compared to the vehicle controls (Figure 2). Observations
from the present study contradict the notion that ROS
generation plays a central role in the mechanism of
rotenone-induced cytotoxicity as 50% cell death was ob-
served without any significant increase in intracellular
ROS levels. Also, minocycline, which neutralized the cyto-
toxic effects of rotenone, significantly increased intracellu-
lar ROS levels, thus providing further support for this
argument. The mechanism by which rotenone decreased
intracellular ROS levels in the present study is not clear.
Both the methanol and ethyl acetate extracts of L.
schweinfurthii and Z. capense countered the decrease in
intracellular ROS caused by rotenone exposure (Figure 2).
Phytochemical analysis of Z. capense has revealed several
bio-active compounds, including alkaloids, lignans, cou-
marins, amides, flavonoids and terpenes [38,49]. The cou-
marins, 7,8-dihydroxy-4-methyl coumarin (DHMC) and
7,8-diacetoxy-4-methyl coumarin (DAMC), and flavonoids
quercetin and quercetin penta-acetate, have been shown
to be potential oxidants [50]. The increases in intracellular
ROS levels, compared to rotenone treatment alone, may
be due to pro-oxidant effects exerted by thesecoumarins and flavonoids. S. puniceus and C. bulbisper-
mum were also observed to inhibit the actions of rote-
none on intracellular ROS levels (Figure 2). In fact,
methanol extracts of both species actually increased
intracellular ROS levels above that of the vehicle controls.
As mentioned earlier, S. puniceus and C. bulbispermum
are known to contain high alkaloid content. Alkaloids
found in this family include heamanthin, distichamine (a.
k.a. buphanidrine) and buphanamine, which are known to
exert toxic effects [21]. It is possible that these alkaloids
possess pro-oxidant effects resulting in the observed
increased intracellular ROS levels.
Intracellular glutathione content
The positive control, NEM, depleted intracellular glutathi-
one content, indicating that the assay produced expected
results (Figure 3). Reduced intracellular glutathione con-
tent was also observed in cells treated with rotenone. This
effect was counteracted by minocycline (Figure 3). As
rotenone exposure did not produce any ROS generation,
it is possible that it may have inhibited enzymes involved
in glutathione synthesis or that it may have formed com-
plexes with glutathione itself, decreasing the intracellular
free reduced glutathione content. It is also possible that
rotenone exposure could have caused the loss of intracel-
lular glutathione by means of membrane leakage [51].
All of the plant extracts exerted effects similar to or
greater than that of minocycline. Most extracts completely
curbed the glutathione depletion induced by rotenone
exposure (Figure 3A and B). The methanol extract of Z.
capense had the greatest effect on intracellular glutathione
content, producing significant increases in glutathione con-
tent in a dose-dependent manner (Figure 3A). Research
has shown that quercetin limits the depletion of intracellu-
lar glutathione content by dehydroascorbic acid in red
blood cells [52]. As Z. capense is known to contain quer-
cetin, this may explain the effects of this plant extract ob-
served in the present study. The highest test concentrations
of the ethyl acetate extracts of both S. puniceus and C. bul-
bispermum also increased intracellular glutathione content
above that of vehicle controls (Figure 3B). Results obtained
with C. bulbispermum align with reports of other members
of the Crinum species, where organic extracts curtailed
glutathione depletion caused by CCl4 exposure in mice
[53].
Mitochondrial membrane potential
Valinomycin (20 μM), the assay positive control, caused a
significant (p < 0.05) reduction in the MMP, compared to
the vehicle controls, indicating that the assay produced ex-
pected results. Compared to vehicle controls, cells exposed
to rotenone showed a significant (p < 0.05) reduction in the
MMP (Figure 4). Minocycline pre-treatment did counteract
the effect observed in cells exposed to rotenone, but the
Figure 4 Mitochondrial disturbances. Mitochondrial membrane potential (MMP) in SH-SY5Y cells exposed to rotenone at 50 nM after 1 h
pre-treatment with either A) methanol or B) ethyl acetate plant extracts following 24 h exposure period. Significant differences from the rotenone
control are indicated by* representing p value < 0.05, while significant differences from vehicle controls are indicated by ■, also representing p
value < 0.05. PC = positive control (minocycline at 10 μM); Rot = rotenone; Untr = Vehicle controls; Valin = valinomycin. (The dashed-line indicates
MMP in the vehicle controls while the dotted-line is indicative of MMP levels in cells exposed to rotenone alone).
Figure 3 Effects on intrinsic antioxidant capacity. Intracellular glutathione content in SH-SY5Y cells exposed to rotenone at 50 nM after 1 h
pre-treatment with either A) methanol or B) ethyl acetate plant extracts following 24 h exposure period. Significant differences from the rotenone
control are indicated by* representing p value < 0.05, while significant differences from vehicle controls are indicated by ■, also representing p value
< 0.05. PC = positive control (minocycline); Rot = rotenone; Untr = Vehicle controls. (The dashed-line indicates intracellular glutathione levels in the
vehicle controls while the dotted-line is indicative of intracellular glutathione content in cells exposed to rotenone alone).
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of mitochondrial complex I, reducing ATP production from
the electron transport chain (ETC) [48,51]. Mitochondrial
uncoupling results in the irreversible formation of a large
mitochondrial membrane permeability transition (MPT)
pore on the inner mitochondrial membrane, which allows
influx and efflux of ions and other large molecules as well
as further dissipation of the MMP [51,54]. Therapeutic
agents that can inhibit MPT pore formation would be
beneficial in preventing MMP reduction and reduction in
ATP production [55].
Generally, pre-treating cells with the methanol extracts of
any one of the plants caused a further reduction in MMP,
when compared to rotenone exposure alone (Figure 4A).
Of the methanol extracts, pre-treatment with L. schwein-
furthii demonstrated the greatest synergistic uncoupling
effect, significantly (p < 0.05) reducing MMP beyond the
effect of rotenone alone at all test concentrations. On the
contrary, most test concentrations of the ethyl acetate
extracts of the individual plants limited the degree to which
rotenone treatment reduced MMP (Figure 4B). Of the ethyl
acetate extracts, C. bulbispermum showed the greatest
inhibition of the uncoupling effect of rotenone exposure.
Most of the tested extracts were not very effective in
preventing the uncoupling effect of rotenone. This may
be due to formation of the MPT pore, which is irreversible
and has been reported to occur within 20 min of the rote-
none apoptogenic effect, once mitochondrial dysfunction
results [51]. Apart from this, MMP is not a staticFigure 5 Apoptotic cell death. Caspase-3 activity in SH-SY5Y cells expos
methanol or B) ethyl acetate plant extracts following 24 h exposure perio
representing p value < 0.05, while significant differences from vehicle contro
control (minocycline at 10 μM); Rot = rotenone; Stauro = staurosporine; Unt
vehicle controls while the dotted-line is indicative of caspase-3 activity in ceparameter and fluctuates with the respiratory needs of the
cell. If a cell requires more energy (high ATP utilization)
the MMP will decrease as ATP production increases. If
less energy is required, the opposite will happen. It is
therefore possible that the decreases in MMP caused by
the plant extracts may be the result of increased ATP
utilization and not necessarily mitochondrial uncoupling
[56].
Apoptosis
Staurosporine, a general apoptosis inducer [57], caused a
significant (p < 0.05) increase in caspase-3 activity, indi-
cating that the assay produced expected results. Rote-
none exposure caused a greater increase in caspase-3
activity than the positive control (Figure 5). This action
was counteracted by minocycline. Rotenone-induced
apoptosis is thought to occur as a consequence of mi-
tochondrial dysfunction, which is triggered by many
factors including: disruption in ATP production, MMP
uncoupling, increased intracellular calcium levels, ROS
generation and glutamate excitotoxicity, in neurons
[51,58]. ATP depletion, due to a depolarized MMP,
ultimately results in MPT pore formation [54]. The pore
allows calcium influx into the cytosol, as well as the irre-
versible release of cytochrome C [51], causing formation
of the apoptosome and subsequent caspase-3 activation.
Minocycline has been reported to inhibit MPT pore
formation thus preventing cytochrome C release result-
ing in suppression of apoptosis [59].ed to rotenone at 50 nM after 1 h pre-treatment with either A)
d. Significant differences from the rotenone control are indicated by*
ls are indicated by ■, also representing p value < 0.05. PC = positive
r = Vehicle controls. (The dashed-line indicates caspase-3 activity in the
lls exposed to rotenone alone).
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served to significantly (p < 0.05) reduce rotenone-induced
caspase-3 activity (Figure 5). Methanol extracts were more
effective than ethyl acetate extracts. Both S. puniceus and
C. bulbispermum methanol extracts (25 μg/ml), were
more effective than minocycline at inhibiting rotenone-
induced caspase-3 activation. Test concentrations of 6.25 -
25 μg/ml of the methanol extract of Z. capense resulted in
a response comparable to that of minocycline (Figure 5A).
Z. capense contains the alkaloid, rutaecarpine [60],
which has been shown to inhibit apoptosis in cardiocytes
subjected to a hypoxia-reoxygenation cycle [61]. It is
possible that this compound may also be responsible for
suppressing caspase-3 activity in the present study.
However, Bao et al. [61] proposed inhibition of NADPH
oxidase-dependent ROS generation as the mechanism
of action of rutaecarpine. As no ROS generation was
observed in the present study this may disqualify rutae-
carpine as the compound responsible for inhibiting
rotenone-induced apoptosis in the present study. This
needs to be confirmed through further experimentation.
Quercetin is another bioactive compounds found in
Z. capense that may have contributed to limiting the
caspase-3 induction caused by rotenone exposure. A
number of studies have reported a neuroprotective
effect of quercetin, specifically related to inhibiting
apoptosis in SH-SY5Y cells [62,63].
Interestingly, a number of compounds isolated from
the methanol extract of Z. capense have been reported
to actually induce apoptosis in cell cultures [60]. These
include compounds like norchelerythrine [64] and epise-
samin [65]. The same is true for the Amaryllidaceae fam-
ily, which is known to contain various pro-apoptotic
alkaloids like crinamine [66] and distichamine [67]. It is
possible that the concentrations of these individual com-
pounds in the crude extracts were too low to induce apop-
tosis in the present study. Apart from this, differences in
cell type may also contribute to any discrepancies.
Conclusion
This is the first study to investigate the effects of L.
schweinfurthii, Z. capense, S. puniceus and C. bulbisper-
mum species on the studied parameters, using an in vitro
PD-like model. These plant extracts limited the depletion
of intracellular glutathione content caused by rotenone
exposure and demonstrated potent anti-apoptotic effects,
warranting further investigations into their neuroprotec-
tive potential.
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